ArticleJournal of hepatocellular carcinoma2026
Large Language Models for Preoperative Microvascular Invasion Prediction in Hepatocellular Carcinoma: A Multicenter Comparison with Radiologists and Treatment Outcomes.
Article in Journal of hepatocellular carcinoma, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Preoperative prediction of microvascular invasion (MVI) in hepatocellular carcinoma (HCC) is critical for prognosis but challenging. This study evaluated the performance of large language models (LLMs) for MVI prediction compared with radiologists with varying levels of experience and explored the association of model-predicted MVI with recurrence and treatment outcomes. Materials and Methods: In this retrospective multicenter study, 602 patients with pathologically confirmed HCC who underwent preoperative MRI and surgical resection were included. GPT-4o and DeepSeek-R1, prompted in English and Chinese using radiology report narratives and predefined MRI features, were compared with six radiologists using histopathology as the reference standard. An independent cohort of 135 patients who underwent radiofrequency ablation (RFA) was included for treatment-outcome analyses. Prediction performance was assessed using diagnostic accuracy and the area under the curve (AUC). Results: GPT-4o (English input) achieved 75.6% accuracy, outperforming residents (59.3%, P < 0.001) and attendings (66.7%, P < 0.001), and was comparable to senior radiologists (74.2%, P = 1.000). DeepSeek-R1 (Chinese input) achieved the highest accuracy (81.2%), outperforming all radiologists (P < 0.05). Residents and attendings showed high sensitivity but relatively low specificity, whereas senior radiologists demonstrated a more balanced performance; while DeepSeek-R1 showed better specificity (up to 94.2%, P < 0.001). LLMs performance were relatively stable across tumor sizes, whereas accuracy among less-experienced radiologists improved with tumor size. AUCs for LLMs (GPT-4o: 75.4%; DeepSeek-R1 Chinese: 80.1%) were superior or comparable to those of radiologists (61.8%-74.5%). Stacking ensemble-predicted MVI-positive status was associated with shorter time-to-recurrence (TTR) in both small (≤3 cm, P = 0.039) and large (>3 cm, P = 0.001) tumors, and with better outcomes following anatomical rather than non-anatomical resection (≤3 cm, P = 0.021; >3 cm, P < 0.001). After propensity score matching, surgical resection was associated with longer TTR than RFA in the model-predicted MVI-positive subgroup, but not in the MVI-negative subgroup. Conclusion: LLMs, particularly DeepSeek-R1 and GPT-4o, demonstrated diagnostic performance for preoperative MVI prediction comparable to or better than that of senior radiologists, with relatively stable performance across tumor sizes and potential value for recurrence-risk stratification and treatment planning.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.